https://www.cochrane.org/fr/CD015849/CENTRALED_le-traitement-par-agonistes-des-recepteurs-du-glp-1-previent-il-les-complications-chez-les-personnes 2025 United Kingdom review of literature french abstract renal insufficiency, chronic kidney diseases diabetes with renal manifestations Glucagon-Like Peptide-1 Receptor diabetic complications glucagon-like peptide 1 chronic disease chronic disease, nos kidney disease, nos receptors, interleukin-1 diabetes complications diabetic nephropathies persons
--- https://www.acadpharm.org/publications/page.php?rb1=50&id_doc=7184 2024 France scientific and technical information parkinson's disease, nos Intensity and Distress 1 One Fear Score 1 Histone-Lysine N-Methyltransferase EHMT1 CDISC SDTM Model Version 1.5 Agreement Score 1 Thought Score 1 Symptoms Extent Score 1 Guadeloupe Phase I Trial Upset Score 1 Glucagon-Like Peptide-1 Receptor Severity of Symptom Score 1 Mild Adverse Event One Hundred Percent One Full Term Pregnancy Illness Intrusiveness Rating 1 Parkinson's Disease Pathway KEGG glucagon-like peptide 1 Never Smoker Parkinson Disease Gleason Grade Group 1 ECOG Performance Status 1 Receptor Neck Pain Score 1 What Month is it 1+ Score, WHO 1+ Score CDISC SDTM Model Version 1.6 Tumor Regression Score 1 Clinical Status Ordinal Scale Outcome 1 parkinson disease
--- https://minerva-ebp.be/FR/Article/2237 2021 false false false Belgium critical appraisal or critical reading Adult body weight semaglutide Diabetes diabetes mellitus exercise glucagon-like peptide 1 dietetics association adulthood nutritionists measures Adult semaglutide overweight glucagon-like peptide 1 adult diabetes mellitus, nos weights and measures
--- https://www.cochrane.org/fr/CD013650/VASC_les-effets-des-inhibiteurs-de-la-dpp-4-des-agonistes-des-recepteurs-du-glp-1-et-des-inhibiteurs-du 2021 United Kingdom review of literature french abstract glucagon-like peptide 1 Glucagon-Like Peptide-1 Receptor cardiovascular diseases disease Glucagon-Like Peptide-2 Receptor persons glucagon-like peptide 2 Diseases of the cardiovascular system dipeptidyl-peptidase iv inhibitors Sodium-Glucose Transporter 2 Inhibitors Diseases Disease premature separation of placenta disease of cardiovascular system, nos